Medical Equipment Industry News

California Auction Event Closing Jan. 26th - Bid Now

Most Read Stories

1) Critical vulnerability makes GE radiological devices vulnerable to hacking

The vulnerability lies in the default passwords of GE's product management software

2) Imaging utilization to drop more than 50% over three or four months: report

After COVID-19, radiology may never be the same again

3) Over 80% drop in SPECT-MPI had no impact on rate of abnormal findings

University of Alabama researchers say restrictions may have reduced unnecessary scans

advertisement

Molecular Imaging Press Room

Automated imaging reveals where TAU protein originates in the brain in Alzheimer's disease
ARTMS and Isotopia Molecular Imaging announce multi-Curie labeling of PSMA-11 with cyclotron produced 68Ga using ARTMS' QIS
Actinium and Astellas announce research collaboration focused on novel Actinium-225 based targeted radiotherapies
Lantheus Holdings announces submission of Drug Master File for NM-01 in the U.S.
ARTMS and Telix Pharmaceuticals announce successful production of PSMA-11 with cyclotron produced 68Ga from a solid target
Blue Earth Diagnostics Phase 3 18F-Fluciclovine PET imaging trial for detection of recurrent brain metastases is underway
Avacta announces license agreement with POINT biopharma Inc.
ImaginAb announces license and supply agreement with Pfizer for CD8 ImmunoPET technology
NorthStar Medical Radioisotopes announces FDA approval for enhanced U.S. Mo-99 radioisotope production capacity
Blue Earth Diagnostics acquires rights to therapeutic applications of Scintomics' rhPSMA technology for prostate cancer

Molecular Imaging

Over 80% drop in SPECT-MPI had no impact on rate of abnormal findings
University of Alabama researchers say restrictions may have reduced unnecessary scans
COVID-19 grounding Canadian cargoes of time-sensitive radioisotopes for cancer treatment
The pandemic has led to fewer transport options and rising shipment costs
New radionuclide enables PET imaging of targeted alpha cancer therapies
Cerium-134 enables imaging of alpha emitters that can treat cancer and spare patients negative side effects
Zionexa distributes first FDA-approved estrogen-receptor-based PET tracer in U.S.
Cerianna can show if tumors are no longer responding to estrogen suppression therapy
Critical vulnerability makes GE radiological devices vulnerable to hacking
The vulnerability lies in the default passwords of GE's product management software
FDA gives nod to first PSMA-targeted PET tracer for prostate cancer
Gallium 68 PSMA-11 is indicated for cases of suspected prostate cancer metastases or suspected prostate cancer recurrence
Digirad to sell DMS Health for over $18 million
DMS Health Technologies provides contract diagnostic imaging through a mobile service
Discounted deals on medical imaging not the safest bet, says new study
Groupons do not include information on risks associated with scans
Fluciclovine PET tracer improves recurrent prostate cancer treatment planning
Resulted in better disease-free survival than conventional imaging
ASTRO research demonstrates high-risk prostate cancer management with PSMA PET/CT
PSMA PET/CT has more sensitivity and specificity than conventional imaging
BWXT and Ontario Power Generation report 'tremendous progress' toward Mo-99 production
Darlington Nuclear Generating Station to become first large-scale nuclear station to produce molybdenum-99
PET and MR imaging reveal two different forms of Parkinson's disease
One form starts in brain, the other in the intestines
PET/MR boosts lesion detection, reduces radiation exposure in cancer imaging
May enable fast, efficient local and whole-body staging in one step
RadioMedix and Curium announce FDA approval of PET agent for neuroendocrine tumors
A copper Cu 64 dotatate injection with a 12.7-hour half-life
Mirion Technologies acquires Biodex Medical Systems
Deal will enhance Mirion's existing portfolio of radiation safety solutions
RLS acquires GE Healthcare's radiopharmacy network
Makes RLS the largest pure molecular imaging focused firm